Ielasi, L.; Tovoli, F.; Tonnini, M.; Tortora, R.; Magini, G.; Sacco, R.; Pressiani, T.; Trevisani, F.; Sansone, V.; Marasco, G.;
et al. Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders. Cancers 2021, 13, 6376.
https://doi.org/10.3390/cancers13246376
AMA Style
Ielasi L, Tovoli F, Tonnini M, Tortora R, Magini G, Sacco R, Pressiani T, Trevisani F, Sansone V, Marasco G,
et al. Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders. Cancers. 2021; 13(24):6376.
https://doi.org/10.3390/cancers13246376
Chicago/Turabian Style
Ielasi, Luca, Francesco Tovoli, Matteo Tonnini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Vito Sansone, Giovanni Marasco,
and et al. 2021. "Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders" Cancers 13, no. 24: 6376.
https://doi.org/10.3390/cancers13246376
APA Style
Ielasi, L., Tovoli, F., Tonnini, M., Tortora, R., Magini, G., Sacco, R., Pressiani, T., Trevisani, F., Sansone, V., Marasco, G., Piscaglia, F., & Granito, A.
(2021). Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders. Cancers, 13(24), 6376.
https://doi.org/10.3390/cancers13246376
